Alexion Pharmaceuticals (ALXN) Share Value Declined While Factory Mutual Insurance Company Upped Position; Lombard Odier Asset Management Switzerland Sa Has Trimmed Its Position in Church & Dwight (CHD) as Stock Value Declined

April 21, 2018 - By Dolores Ford

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Logo

Factory Mutual Insurance Company increased its stake in Alexion Pharmaceuticals Inc (ALXN) by 104.51% based on its latest 2017Q4 regulatory filing with the SEC. Factory Mutual Insurance Company bought 183,200 shares as the company’s stock declined 8.80% with the market. The institutional investor held 358,500 shares of the health care company at the end of 2017Q4, valued at $42.87 million, up from 175,300 at the end of the previous reported quarter. Factory Mutual Insurance Company who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be bullish on the $23.97B market cap company. The stock decreased 3.54% or $3.96 during the last trading session, reaching $107.78. About 5.04 million shares traded or 132.24% up from the average. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 8.84% since April 21, 2017 and is downtrending. It has underperformed by 20.39% the S&P500.

Lombard Odier Asset Management Switzerland Sa decreased its stake in Church & Dwight Inc (CHD) by 12.72% based on its latest 2017Q4 regulatory filing with the SEC. Lombard Odier Asset Management Switzerland Sa sold 13,142 shares as the company’s stock declined 3.78% with the market. The institutional investor held 90,207 shares of the basic industries company at the end of 2017Q4, valued at $4.53M, down from 103,349 at the end of the previous reported quarter. Lombard Odier Asset Management Switzerland Sa who had been investing in Church & Dwight Inc for a number of months, seems to be less bullish one the $11.19 billion market cap company. The stock decreased 5.91% or $2.88 during the last trading session, reaching $45.84. About 4.58 million shares traded or 111.79% up from the average. Church & Dwight Co., Inc. (NYSE:CHD) has declined 4.22% since April 21, 2017 and is downtrending. It has underperformed by 15.77% the S&P500.

Since January 2, 2018, it had 0 buys, and 12 insider sales for $4.62 million activity. $389,099 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares were sold by Moriarty John B. HANTSON LUDWIG had sold 2,553 shares worth $310,521 on Tuesday, January 2. Wagner Heidi L had sold 698 shares worth $83,305. Franchini Indrani Lall sold 1,459 shares worth $169,696. $192,028 worth of stock was sold by Goff Brian on Tuesday, February 6. On Tuesday, February 6 Clancy Paul J sold $707,048 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) or 6,079 shares.

Investors sentiment decreased to 1.03 in 2017 Q4. Its down 0.14, from 1.17 in 2017Q3. It dived, as 65 investors sold ALXN shares while 171 reduced holdings. 64 funds opened positions while 178 raised stakes. 204.38 million shares or 1.21% less from 206.89 million shares in 2017Q3 were reported. Bank & Trust Of Mellon reported 3.11 million shares. Eaton Vance Management owns 1.10 million shares. Moreover, Conning Incorporated has 0.02% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 5,130 shares. 372,039 were reported by Dimensional Fund Advsr L P. 25,990 were accumulated by State Of Alaska Department Of Revenue. Gabelli Funds Limited Company holds 0.02% or 34,200 shares. 2,983 were reported by Private Advisor Gru Ltd Liability Company. Bessemer Group Inc accumulated 725,496 shares or 0.34% of the stock. Proshare Advisors Limited Liability Company has 0.22% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 260,933 shares. Livforsakringsbolaget Skandia Omsesidigt has invested 0.04% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Hbk Investments Ltd Partnership stated it has 2,619 shares or 0% of all its holdings. Ngam Advisors Ltd Partnership has invested 0.02% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Premier Asset Limited Liability Corporation has invested 0.28% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Sumitomo Mitsui Asset Ltd holds 0.03% or 16,277 shares. Robeco Institutional Asset Mngmt Bv owns 0.01% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 15,980 shares.

Among 29 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 25 have Buy rating, 0 Sell and 4 Hold. Therefore 86% are positive. Alexion Pharmaceuticals Inc. had 105 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Buy” rating by Goldman Sachs given on Friday, October 28. The firm has “Outperform” rating by Robert W. Baird given on Monday, December 18. The company was initiated on Thursday, February 25 by Citigroup. RBC Capital Markets maintained the shares of ALXN in report on Thursday, December 22 with “Outperform” rating. As per Thursday, May 25, the company rating was upgraded by Morgan Stanley. The company was downgraded on Monday, September 14 by Barclays Capital. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Buy” rating by Oppenheimer on Tuesday, August 15. The firm has “Overweight” rating given on Tuesday, June 7 by Morgan Stanley. As per Thursday, July 27, the company rating was maintained by Stifel Nicolaus. On Friday, February 9 the stock rating was maintained by Citigroup with “Buy”.

Factory Mutual Insurance Company, which manages about $9.56B US Long portfolio, decreased its stake in Express Scripts Hldg Co (NASDAQ:ESRX) by 207,100 shares to 546,248 shares, valued at $40.77M in 2017Q4, according to the filing. It also reduced its holding in Adobe Sys Inc (NASDAQ:ADBE) by 53,650 shares in the quarter, leaving it with 285,350 shares, and cut its stake in Johnson Ctls Intl Plc.

Lombard Odier Asset Management Switzerland Sa, which manages about $1.03 billion US Long portfolio, upped its stake in Aflac Inc (NYSE:AFL) by 37,077 shares to 41,380 shares, valued at $3.63 million in 2017Q4, according to the filing. It also increased its holding in Stanley Black & Decker Inc (NYSE:SWK) by 13,734 shares in the quarter, for a total of 15,317 shares, and has risen its stake in Bce Inc (NYSE:BCE).

Since February 26, 2018, it had 0 buys, and 4 sales for $25.60 million activity. On Friday, March 9 KATZ STEVEN J sold $638,319 worth of Church & Dwight Co., Inc. (NYSE:CHD) or 12,600 shares.

Investors sentiment increased to 0.96 in 2017 Q4. Its up 0.01, from 0.95 in 2017Q3. It improved, as 50 investors sold CHD shares while 220 reduced holdings. 67 funds opened positions while 192 raised stakes. 197.64 million shares or 0.87% more from 195.93 million shares in 2017Q3 were reported. Acadian Asset Mgmt accumulated 0.12% or 567,808 shares. Mountain Pacific Inv Advisers Id has 381,219 shares for 2.01% of their portfolio. Wellington Shields Cap Management Limited Liability Corp reported 0.07% of its portfolio in Church & Dwight Co., Inc. (NYSE:CHD). State Treasurer State Of Michigan invested in 73,224 shares or 0.03% of the stock. Kentucky Retirement has 0.06% invested in Church & Dwight Co., Inc. (NYSE:CHD) for 15,412 shares. M&T Financial Bank Corp has 134,153 shares for 0.04% of their portfolio. The New York-based Global X Mngmt Ltd Com has invested 0.01% in Church & Dwight Co., Inc. (NYSE:CHD). Addenda Cap Incorporated holds 0.28% of its portfolio in Church & Dwight Co., Inc. (NYSE:CHD) for 80,266 shares. 3,870 were reported by Stratos Wealth Prtn Limited. Millennium Mngmt Ltd Co holds 0% or 50,425 shares. Eads Heald Invest Counsel, a Georgia-based fund reported 42,607 shares. Cibc World Markets holds 0.02% of its portfolio in Church & Dwight Co., Inc. (NYSE:CHD) for 60,119 shares. Pittenger And Anderson invested in 0.28% or 64,290 shares. Cubist Systematic Strategies Ltd Limited Liability Company stated it has 40,922 shares. Tudor Investment Et Al reported 25,702 shares.

Among 21 analysts covering Church & Dwight (NYSE:CHD), 4 have Buy rating, 5 Sell and 12 Hold. Therefore 19% are positive. Church & Dwight had 63 analyst reports since July 21, 2015 according to SRatingsIntel. BMO Capital Markets maintained Church & Dwight Co., Inc. (NYSE:CHD) on Tuesday, February 6 with “Hold” rating. The company was maintained on Tuesday, June 13 by Jefferies. The stock has “Underweight” rating by Barclays Capital on Tuesday, November 7. The firm has “Buy” rating by Jefferies given on Friday, August 5. The rating was maintained by Williams Capital Group on Thursday, August 6 with “Buy”. The stock has “Buy” rating by Jefferies on Friday, October 27. The company was upgraded on Wednesday, February 7 by Oppenheimer. Jefferies maintained it with “Buy” rating and $58 target in Friday, November 3 report. The firm has “Underweight” rating by Morgan Stanley given on Friday, November 3. As per Monday, July 17, the company rating was maintained by Jefferies.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: